Literature DB >> 15743856

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.

Kirsten Duckitt1, Deborah Harrington.   

Abstract

OBJECTIVE: To determine the risk of pre-eclampsia associated with factors that may be present at antenatal booking.
DESIGN: Systematic review of controlled studies published 1966-2002. DATA SYNTHESIS: Unadjusted relative risks were calculated from published data.
RESULTS: Controlled cohort studies showed that the risk of pre-eclampsia is increased in women with a previous history of pre-eclampsia (relative risk 7.19, 95% confidence interval 5.85 to 8.83) and in those with antiphospholipids antibodies (9.72, 4.34 to 21.75), pre-existing diabetes (3.56, 2.54 to 4.99), multiple (twin) pregnancy (2.93, 2.04 to 4.21), nulliparity (2.91, 1.28 to 6.61), family history (2.90, 1.70 to 4.93), raised blood pressure (diastolic > or = 80 mm Hg) at booking (1.38, 1.01 to 1.87), raised body mass index before pregnancy (2.47, 1.66 to 3.67) or at booking (1.55, 1.28 to 1.88), or maternal age > or = 40 (1.96, 1.34 to 2.87, for multiparous women). Individual studies show that risk is also increased with an interval of 10 years or more since a previous pregnancy, autoimmune disease, renal disease, and chronic hypertension.
CONCLUSIONS: These factors and the underlying evidence base can be used to assess risk at booking so that a suitable surveillance routine to detect pre-eclampsia can be planned for the rest of the pregnancy.

Entities:  

Mesh:

Year:  2005        PMID: 15743856      PMCID: PMC554027          DOI: 10.1136/bmj.38380.674340.E0

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  58 in total

1.  Obesity and related pregnancy complications in an inner-city clinic.

Authors:  D Bowers; W R Cohen
Journal:  J Perinatol       Date:  1999 Apr-May       Impact factor: 2.521

2.  Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  1988-01       Impact factor: 8.661

3.  Pre-eclampsia in second pregnancy.

Authors:  D M Campbell; I MacGillivray; R Carr-Hill
Journal:  Br J Obstet Gynaecol       Date:  1985-02

4.  Meta-analysis of clinical trials as a scientific discipline. I: Control of bias and comparison with large co-operative trials.

Authors:  T C Chalmers; H Levin; H S Sacks; D Reitman; J Berrier; R Nagalingam
Journal:  Stat Med       Date:  1987 Apr-May       Impact factor: 2.373

5.  Preeclampsia in diabetic pregnancies.

Authors:  P R Garner; M E D'Alton; D K Dudley; P Huard; M Hardie
Journal:  Am J Obstet Gynecol       Date:  1990-08       Impact factor: 8.661

6.  Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986.

Authors:  A F Saftlas; D R Olson; A L Franks; H K Atrash; R Pokras
Journal:  Am J Obstet Gynecol       Date:  1990-08       Impact factor: 8.661

7.  Pregnancies in women with and without renal scarring after urinary infections in childhood.

Authors:  J Martinell; U Jodal; G Lidin-Janson
Journal:  BMJ       Date:  1990-03-31

8.  The association of antiphospholipid antibodies with severe preeclampsia.

Authors:  D W Branch; R Andres; K B Digre; N S Rote; J R Scott
Journal:  Obstet Gynecol       Date:  1989-04       Impact factor: 7.661

9.  Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis.

Authors:  B M Sibai; A el-Nazer; A Gonzalez-Ruiz
Journal:  Am J Obstet Gynecol       Date:  1986-11       Impact factor: 8.661

10.  Retrospective comparison of blood pressure course during preeclamptic and matched control pregnancies.

Authors:  R E Reiss; R W O'Shaughnessy; T J Quilligan; F P Zuspan
Journal:  Am J Obstet Gynecol       Date:  1987-04       Impact factor: 8.661

View more
  366 in total

1.  Upregulation of sFlt-1 by trophoblasts induces the barrier dysfunction of glomerular endothelial cells.

Authors:  Jun Zhao; Haiyi Liu; Hui Du; Fuyuan Qiao; Yvqi Li; Xinwei Shi; Xun Gong; Yuanyuan Wu; Qiong Zhou; Jingjing Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

2.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 3.  [The heart during pregnancy].

Authors:  Michael E Hall; Eric M George; Joey P Granger
Journal:  Rev Esp Cardiol       Date:  2011-10-01       Impact factor: 4.753

4.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

5.  Increased placental telomerase mRNA in hypertensive disorders of pregnancy.

Authors:  Ossie Geifman-Holtzman; Yali Xiong; Eliezer J Holtzman; Barbara Hoffman; John Gaughan; Dan A Liebermann
Journal:  Hypertens Pregnancy       Date:  2010       Impact factor: 2.108

6.  Isolated proteinuria is a risk factor for pre-eclampsia: a retrospective analysis of the maternal and neonatal outcomes in women presenting with isolated gestational proteinuria.

Authors:  S Shinar; J Asher-Landsberg; A Schwartz; M Ram-Weiner; M J Kupferminc; A Many
Journal:  J Perinatol       Date:  2015-10-29       Impact factor: 2.521

7.  VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population.

Authors:  Melissa D Amosco; Van Anthony M Villar; Justin Michael A Naniong; Lara Marie G David-Bustamante; Pedro A Jose; Cynthia P Palmes-Saloma
Journal:  Clin Exp Hypertens       Date:  2016-09-26       Impact factor: 1.749

8.  Chronic hyperleptinemia results in the development of hypertension in pregnant rats.

Authors:  Ana C Palei; Frank T Spradley; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-11       Impact factor: 3.619

9.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

10.  Placental abruption and subsequent risk of pre-eclampsia: a population-based case-control study.

Authors:  Samantha E Parker; Martha M Werler; Mika Gissler; Minna Tikkanen; Cande V Ananth
Journal:  Paediatr Perinat Epidemiol       Date:  2015-03-11       Impact factor: 3.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.